Alzheimer's Disease Neuroimaging Initiative (ADNI)

Alzheimer's Disease Neuroimaging Initiative (ADNI)

Introduction

The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a landmark longitudinal study launched in 2004 to define the progression of [Alzheimer's Disease](/diseases/alzheimers-disease) by integrating multimodal neuroimaging with clinical and biomarker data. ADNI has become one of the most influential datasets in neuroscience, with over 10,000 publications citing the study.

Study Design

Phases

ADNI has progressed through multiple phases:

Alzheimer's Disease Neuroimaging Initiative (ADNI)

Introduction

The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a landmark longitudinal study launched in 2004 to define the progression of [Alzheimer's Disease](/diseases/alzheimers-disease) by integrating multimodal neuroimaging with clinical and biomarker data. ADNI has become one of the most influential datasets in neuroscience, with over 10,000 publications citing the study.

Study Design

Phases

ADNI has progressed through multiple phases:

Cohort Composition

The study includes:[@peterson2009]

• Cognitively normal controls
• Individuals with [Mild Cognitive Impairment](/diseases/mild-cognitive-impairment)
• Patients with mild to moderate Alzheimer's Disease

Data Collection

Each participant undergoes:[@weiner2010]

• MRI: Structural brain imaging at multiple time points
• PET: FDG-PET and amyloid-PET imaging
• CSF: Lumbar punctures for biomarker analysis
• Clinical assessments: Cognitive testing, functional assessments
• Genetic testing: APOE genotyping

Key Datasets

Neuroimaging

ADNI provides:[@weiner2012]

• T1-weighted MRI scans for volumetric analysis
• FDG-PET for glucose metabolism
• Amyloid-PET (Florbetapir) imaging
• Diffusion MRI for white matter integrity

Biomarkers

• CSF Abeta-40, Abeta-42: Amyloid markers
• CSF tau, p-tau: Neurodegeneration markers
• Plasma biomarkers: Emerging blood-based markers

Genetic Data

• APOE genotyping: Major genetic risk factor
• Genome-wide data: GWAS capabilities
• Whole genome sequencing: In subsets

Major Findings

Biomarker Trajectories

ADNI established the temporal ordering of biomarker changes in AD:[@jack2010]

Disease Progression

The study has defined the natural history of [MCI due to AD](/diseases/mild-cognitive-impairment):[@veitch2019]

• Conversion rates from MCI to AD
• Predictors of progression
• Role of amyloid and tau

Clinical Trials

ADNI has transformed clinical trial design by:[@weiner2013]

• Enrichment strategies using biomarkers
• Outcome measures validation
• Sample size calculations

Brain Atrophy Patterns

Longitudinal MRI has revealed characteristic patterns of brain atrophy in AD, particularly in the [hippocampus](/brain-regions/hippocampus) and entorhinal cortex. [@jane2018]

Prediction Models

Data support machine learning models for predicting progression from MCI to AD, integrating imaging, genetic, and biomarker data. [@muirhead2020]

Impact on the Field

ADNI has had transformative impact:[@sabuncu2021]

• Established standardized imaging protocols
• Enabled biomarker validation
• Supported drug development
• Created open-access data resources

Data Access

ADNI data are freely available to qualified researchers:[@adni2024]

• Registration: https://adni.loni.usc.edu
• Data download: LONI Image Repository
• Publications: ADNI publications database

Cross-Links to Related Pages

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Mild Cognitive Impairment](/diseases/mild-cognitive-impairment)

Related Brain Regions

• [Hippocampus](/brain-regions/hippocampus)
• [Entorhinal Cortex](/brain-regions/entorhinal-cortex)
• [Cerebral Cortex](/brain-regions/cerebral-cortex)

Related Genes

• [APOE](/genes/apoe)

Related Biomarkers

• [Amyloid Beta](/biomarkers/amyloid-beta)
• [Tau Proteins](/biomarkers/tau-proteins)
• [CSF Biomarkers](/diagnostics/csf-biomarkers)
• [PET Imaging](/diagnostics/pet-imaging)

Related Datasets

• [OASIS](/datasets/oasis)
• [UK Biobank](/datasets/uk-biobank)

External Links

• [ADNI Official Website](https://adni.loni.usc.edu)
• [ADNI Data Repository](https://adni.loni.usc.edu/data/)
• [ADNI Publications](https://adni.loni.usc.edu/publications/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Alzheimer's Disease Neuroimaging Initiative (ADNI) discovered through SciDEX knowledge graph analysis: